3 investing lessons from Angel Insights with Sarah Turner
5 mins. to read
A few takeaways for investors from crowdfunding experts SyndicateRoom’s latest podcast.
Partner Content
Breaking down the barriers to ownership: How WiseAlpha built an open bond marketplace
5 mins. to read
Rezaah Ahmad, CEO of WiseAlpha, gives the inside track on how his company is driving down barriers to ownership with a fair and affordable access point to a superior asset class.
We are what we eat: Jim Mellon exclusive
7 mins. to read
Longevity, biotech, investment, sustainability and ethics: Jim Mellon’s new book, MOO’S LAW, addresses the opportunities and challenges of our need for protein.
Busting some of the common myths about investing in private equity
8 mins. to read
Helen Steers, Partner at Pantheon and Manager of Pantheon International Plc (PIP), addresses some of the common myths surrounding private equity.
Longevity market blockbuster? Senolytic drug development is attracting investor interest
5 mins. to read
By killing so-called zombie cells which accelerate the ageing process, drugs called senolytics promise to keep us younger and fitter for longer.
Longevity Market Watch: The Longevity doctor will see you now
3 mins. to read
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
Longevity Market Watch
5 mins. to read
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
Longevity Week Review
4 mins. to read
Michael Corcoran and James Lawford Davies of Hill Dickinson discuss the firm’s participation in Longevity Week and the longevity sector in general.
Longevity Market Watch
5 mins. to read
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
Longevity Market Watch
4 mins. to read
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.